" class="no-js "lang="en-US"> Nicholas Oughtibridge - Medtech Alert
Thursday, May 15, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Nicholas Oughtibridge

Nicholas Oughtibridge

About Nicholas Oughtibridge

I enable the best use of health and care records by patients, their care providers, computers, managers and researchers.
Key goal – to establish a portable care record for citizens and their care givers, wherever they are.

Related Story

News

 NHS Digital Terminology Server Goes Live | Pharmtech Focus

NHS Digital Terminology Server Goes Live

June 15 2021

NHS Digital’s Terminology Server, a solution which enables healthcare IT systems to speak the same […]